• Voyager Therapeutics awarded President Robin Swartz 68,250 common shares on November 1, 2026.
• Swartz also received options to buy 318,500 common shares at $1.72 per share, expiring November 1, 2036.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyager Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-445316), on November 03, 2026, and is solely responsible for the information contained therein.